|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | Pfizer |
|---|---|
| Information provided by: | Pfizer |
| ClinicalTrials.gov Identifier: | NCT00143234 |
Purpose
The purpose of the study is to measure the effect of the amlodipine/atorvastatin combination pill in reducing both elevated blood pressure and cholesterol levels to levels suggested by guidelines
| Condition | Intervention | Phase |
|---|---|---|
|
Hypertension Hyperlipidemia |
Drug: Amlodipine/atorvastatin single pill |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Clinical Utility of Amlodipine/Atorvastatin to Improve Concomitant Cardiovascular Risk Factors of Hypertension and Dyslipidemia |
| Estimated Enrollment: | 1825 |
| Study Start Date: | May 2004 |
| Estimated Study Completion Date: | July 2005 |
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
Hide Study Locations| Argentina | |
| Pfizer Investigational Site | |
| Buenos Aires, Argentina, C1437JCP | |
| Pfizer Investigational Site | |
| Buenos Aires, Argentina, C1181ACH | |
| Pfizer Investigational Site | |
| Buenos Aires, Argentina, C1425ASS | |
| Pfizer Investigational Site | |
| Buenos Aires, Argentina, C1431FWO | |
| Pfizer Investigational Site | |
| Buenos Aires, Argentina, C1428DCO | |
| Argentina, Buenos Aires | |
| Pfizer Investigational Site | |
| Unknown, Buenos Aires, Argentina, C1221ACI | |
| Australia, New South Wales | |
| Pfizer Investigational Site | |
| ST. LEONARDS, New South Wales, Australia, 2065 | |
| Australia, Queensland | |
| Pfizer Investigational Site | |
| Southport, Queensland, Australia, 4215 | |
| Pfizer Investigational Site | |
| Woolloongabba, Queensland, Australia, 4102 | |
| Australia, Victoria | |
| Pfizer Investigational Site | |
| PRAHRAN, Victoria, Australia, 3181 | |
| Pfizer Investigational Site | |
| Melbourne, Victoria, Australia, 3004 | |
| Pfizer Investigational Site | |
| Heidelberg, Victoria, Australia, 3084 | |
| Australia, Western Australia | |
| Pfizer Investigational Site | |
| Fremantle, Western Australia, Australia, 6160 | |
| Brazil, mg | |
| Pfizer Investigational Site | |
| Belo Horizonte, mg, Brazil, 30110-060 | |
| Pfizer Investigational Site | |
| Belo Horizonte, mg, Brazil, 30150-221 | |
| Pfizer Investigational Site | |
| Belo Horizonte, mg, Brazil, 30130-110 | |
| Brazil, PE | |
| Pfizer Investigational Site | |
| Recife, PE, Brazil, 50670-901 | |
| Brazil, SP | |
| Pfizer Investigational Site | |
| Botucatu, SP, Brazil, 18618-000 | |
| Pfizer Investigational Site | |
| Sao Paulo, SP, Brazil, 01244-030 | |
| Pfizer Investigational Site | |
| Ribeirao Preto, SP, Brazil, 14048-900 | |
| Pfizer Investigational Site | |
| São Paulo, SP, Brazil, 04038-002 | |
| Pfizer Investigational Site | |
| Campinas, SP, Brazil, 13012-000 | |
| Chile, Región Metropolitana | |
| Pfizer Investigational Site | |
| Santiago, Región Metropolitana, Chile | |
| Chile, RM | |
| Pfizer Investigational Site | |
| Santiago, RM, Chile | |
| Guatemala | |
| Pfizer Investigational Site | |
| Guatemala, Guatemala, 01015 | |
| Hong Kong | |
| Pfizer Investigational Site | |
| Sai ying Pun, Hong Kong | |
| Pfizer Investigational Site | |
| Sai Ying Pun, Hong Kong | |
| Pfizer Investigational Site | |
| Pokfulam Road, Hong Kong | |
| Pfizer Investigational Site | |
| Unknown, Hong Kong | |
| India | |
| Pfizer Investigational Site | |
| New Delhi, India, 100 025 | |
| Pfizer Investigational Site | |
| New Delhi, India, 11050 | |
| Pfizer Investigational Site | |
| New Delhi, India, 110 026 | |
| India, Andhra Pradesh | |
| Pfizer Investigational Site | |
| Hyderabad, Andhra Pradesh, India, 500 001 | |
| Pfizer Investigational Site | |
| Hyderabad, Andhra Pradesh, India, 500 033 | |
| India, Karnataka | |
| Pfizer Investigational Site | |
| Bangalore, Karnataka, India, 562158 | |
| India, MAHARASHTRA | |
| Pfizer Investigational Site | |
| Pune, MAHARASHTRA, India, 411 001 | |
| India, Maharashtra | |
| Pfizer Investigational Site | |
| Mumbai, Maharashtra, India, 400 007 | |
| India, Nagpada Junction | |
| Pfizer Investigational Site | |
| Mumbai, Nagpada Junction, India, 400 008 | |
| Indonesia | |
| Pfizer Investigational Site | |
| Jakarta, Indonesia, 10430 | |
| Pfizer Investigational Site | |
| Surabaya, Indonesia, 60286 | |
| Pfizer Investigational Site | |
| Jakarta, Indonesia, 11420 | |
| Israel | |
| Pfizer Investigational Site | |
| Jerusalem, Israel, 91120 | |
| Pfizer Investigational Site | |
| Tel Hashomer, Israel, 52621 | |
| Pfizer Investigational Site | |
| Rehovot, Israel, 76100 | |
| Pfizer Investigational Site | |
| Tel Aviv, Israel, 64239 | |
| Pfizer Investigational Site | |
| Jerusalem, Israel, 91240 | |
| Jordan | |
| Pfizer Investigational Site | |
| Amman, Jordan, 11942 | |
| Pfizer Investigational Site | |
| Amman, Jordan | |
| Korea, Republic of | |
| Pfizer Investigational Site | |
| Seoul, Korea, Republic of, 110-799 | |
| Pfizer Investigational Site | |
| Seoul, Korea, Republic of, 136-705 | |
| Pfizer Investigational Site | |
| Seoul, Korea, Republic of, 152-703 | |
| Korea, Republic of, Busan | |
| Pfizer Investigational Site | |
| Seo-gu, Busan, Korea, Republic of, 602-739 | |
| Korea, Republic of, Daegu | |
| Pfizer Investigational Site | |
| Jung-gu, Daegu, Korea, Republic of, 700-721 | |
| Korea, Republic of, Kwangji | |
| Pfizer Investigational Site | |
| Dong-gu, Kwangji, Korea, Republic of, 501-757 | |
| Korea, Republic of, Kyungki-do | |
| Pfizer Investigational Site | |
| Anyang-city, Kyungki-do, Korea, Republic of, 431-070 | |
| Pfizer Investigational Site | |
| Guri-City, Kyungki-do, Korea, Republic of, 471-701 | |
| Korea, Republic of, Seoul | |
| Pfizer Investigational Site | |
| Gangnam-gu, Seoul, Korea, Republic of, 135-710 | |
| Pfizer Investigational Site | |
| Yongdeungpo-gu, Seoul, Korea, Republic of, 150-713 | |
| Kuwait | |
| Pfizer Investigational Site | |
| Sasat, Kuwait, Zip Code 13110 | |
| Lebanon | |
| Pfizer Investigational Site | |
| Beirut, Lebanon | |
| Pfizer Investigational Site | |
| Unknown, Lebanon | |
| Malaysia | |
| Pfizer Investigational Site | |
| Kuala Lumpur, Malaysia, 50586 | |
| Pfizer Investigational Site | |
| Kuala Lumpur, Malaysia, 59100 | |
| Malaysia, Kelantan | |
| Pfizer Investigational Site | |
| Kubang Kerian, Kelantan, Malaysia, 16150 | |
| Malaysia, Negeri Sembilan | |
| Pfizer Investigational Site | |
| Seremban, Negeri Sembilan, Malaysia, 70400 | |
| Malaysia, Sarawak | |
| Pfizer Investigational Site | |
| Kuching, Sarawak, Malaysia | |
| Mexico | |
| Pfizer Investigational Site | |
| PUEBLA, Mexico, 72000 | |
| Pfizer Investigational Site | |
| MEXICO, Mexico, 14000 | |
| Pfizer Investigational Site | |
| Aguascalientes, Mexico, C.P. 20230 | |
| Pfizer Investigational Site | |
| METEPEC, Mexico, 52140 | |
| Pfizer Investigational Site | |
| SAN LUIS POTOSI, Mexico, 78210 | |
| Mexico, D.F | |
| Pfizer Investigational Site | |
| Mexico, D.F, Mexico, 14000 | |
| Morocco | |
| Pfizer Investigational Site | |
| Casablanca, Morocco, 20000 | |
| Pakistan, N.W.F.P. | |
| Pfizer Investigational Site | |
| Peshawar, N.W.F.P., Pakistan | |
| Pakistan, Punjab | |
| Pfizer Investigational Site | |
| Islamabad, Punjab, Pakistan | |
| Pfizer Investigational Site | |
| Faisalabad, Punjab, Pakistan | |
| Pfizer Investigational Site | |
| Lahore, Punjab, Pakistan | |
| Peru | |
| Pfizer Investigational Site | |
| Lima, Peru, L27 | |
| Philippines | |
| Pfizer Investigational Site | |
| QUEZON CITY, Philippines | |
| Pfizer Investigational Site | |
| Quezon City, Philippines, 1100 | |
| Pfizer Investigational Site | |
| Quezon City, Philippines | |
| Pfizer Investigational Site | |
| Manila, Philippines | |
| Pfizer Investigational Site | |
| Filinvest, Alabang, Philippines | |
| Philippines, Metro Manila | |
| Pfizer Investigational Site | |
| San Juan, Metro Manila, Philippines | |
| Philippines, Taft Avenue, Manila City | |
| Pfizer Investigational Site | |
| Phippine General Hospital, Taft Avenue, Manila City, Philippines, Manila | |
| Saudi Arabia | |
| Pfizer Investigational Site | |
| Riyadh, Saudi Arabia, 11461 | |
| Pfizer Investigational Site | |
| Riyadh, Saudi Arabia, 11426 | |
| Pfizer Investigational Site | |
| Al-Khobar, Saudi Arabia | |
| Singapore | |
| Pfizer Investigational Site | |
| Singapore, Singapore, 168752 | |
| Pfizer Investigational Site | |
| Singapore, Singapore, 119074 | |
| South Africa | |
| Pfizer Investigational Site | |
| Cape Town, South Africa, 7129 | |
| Pfizer Investigational Site | |
| Cape Town, South Africa, 7405 | |
| Pfizer Investigational Site | |
| Cape Town, South Africa | |
| Pfizer Investigational Site | |
| Gauteng, South Africa, 2059 | |
| South Africa, Cape Province | |
| Pfizer Investigational Site | |
| Worcester, Cape Province, South Africa | |
| South Africa, GAUTENG | |
| Pfizer Investigational Site | |
| MIDRAND, JOHANNESBURG, GAUTENG, South Africa, 1685 | |
| Pfizer Investigational Site | |
| ARCADIA, PRETORIA, GAUTENG, South Africa, 0083 | |
| South Africa, Gauteng | |
| Pfizer Investigational Site | |
| Sunnyside, Pretoria, Gauteng, South Africa, 0002 | |
| South Africa, Kwa-Zulu Natal | |
| Pfizer Investigational Site | |
| 4091, Kwa-Zulu Natal, South Africa | |
| South Africa, NATAL | |
| Pfizer Investigational Site | |
| CHATSWORTH, NATAL, South Africa, 4092 | |
| Taiwan | |
| Pfizer Investigational Site | |
| Taipei, Taiwan, 114 | |
| Pfizer Investigational Site | |
| Changhua City, Taiwan, 500 | |
| Pfizer Investigational Site | |
| Taipei, Taiwan, 100 | |
| Pfizer Investigational Site | |
| Taipei, Taiwan, 112 | |
| Taiwan, Kaohsiung | |
| Pfizer Investigational Site | |
| Niao-Sung Hsiang, Kaohsiung, Taiwan, 833 | |
| Taiwan, Tau-Yuan Shian | |
| Pfizer Investigational Site | |
| Guei-Shan Shiang, Tau-Yuan Shian, Taiwan, 333 | |
| Thailand | |
| Pfizer Investigational Site | |
| Chiang Mai, Thailand, 50200 | |
| Pfizer Investigational Site | |
| BANGKOK, Thailand, 10400 | |
| Thailand, BANGKOK | |
| Pfizer Investigational Site | |
| KHET RAJATHEVEE, BANGKOK, Thailand, 10400 | |
| Tunisia | |
| Pfizer Investigational Site | |
| Tunis, Tunisia | |
| Pfizer Investigational Site | |
| Tunis, Tunisia | |
| Turkey | |
| Pfizer Investigational Site | |
| ISTANBUL, Turkey | |
| Pfizer Investigational Site | |
| ANTALYA, Turkey, 07059 | |
| Pfizer Investigational Site | |
| ADANA, Turkey, 01330 | |
| Pfizer Investigational Site | |
| DIYARBAKIR, Turkey, 21280 | |
| Turkey, ANKARA | |
| Pfizer Investigational Site | |
| CEBECI, ANKARA, Turkey, 06100 | |
| Pfizer Investigational Site | |
| SIHHIYE, ANKARA, Turkey, 06100 | |
| Turkey, Gaziantep | |
| Pfizer Investigational Site | |
| Unknown, Gaziantep, Turkey | |
| Turkey, ISTANBUL | |
| Pfizer Investigational Site | |
| HAYDARPASA, ISTANBUL, Turkey, 81010 | |
| Turkey, IZMIR | |
| Pfizer Investigational Site | |
| ALSANCAK, IZMIR, Turkey | |
| Turkey, KAYSERI | |
| Pfizer Investigational Site | |
| TALAS, KAYSERI, Turkey, 38039 | |
| United Arab Emirates | |
| Pfizer Investigational Site | |
| Sharjah, United Arab Emirates | |
| Pfizer Investigational Site | |
| Dubai, United Arab Emirates | |
| Pfizer Investigational Site | |
| Abu Dhabi, United Arab Emirates | |
| Study Director: | Pfizer CT.gov Call Center | Pfizer |
More Information
| Study ID Numbers: | A3841024 |
| Study First Received: | August 31, 2005 |
| Last Updated: | October 2, 2008 |
| ClinicalTrials.gov Identifier: | NCT00143234 History of Changes |
| Health Authority: | Taiwan: Department of Health |
|
Antimetabolites Vasodilator Agents Hyperlipidemias Metabolic Diseases Molecular Mechanisms of Pharmacological Action Antilipemic Agents Vascular Diseases Calcium Channel Blockers Enzyme Inhibitors Anticholesteremic Agents Cardiovascular Agents |
Hydroxymethylglutaryl-CoA Reductase Inhibitors Antihypertensive Agents Pharmacologic Actions Amlodipine Membrane Transport Modulators Therapeutic Uses Cardiovascular Diseases Dyslipidemias Atorvastatin Hypertension Lipid Metabolism Disorders |
